Pfizer Inc (PFE)

Frankfurt
Currency in EUR
25.09
-0.42(-1.63%)
Delayed Data

PFE Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa41,65181,288100,33058,49663,627
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1.82%+95.16%+23.43%-41.7%+8.77%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa8,38530,68634,09723,98916,420
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa33,26650,60266,23334,50747,207
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+0.63%+52.11%+30.89%-47.9%+36.8%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa79.87%62.25%66.02%58.99%74.19%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa23,47523,62227,23729,24830,879
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-5.78%+0.63%+15.3%+7.38%+5.58%
aa.aaaa.aaaa.aaaa.aaaa.aa8,70910,36011,42810,67910,822
aa.aaaa.aaaa.aaaa.aaaa.aa11,4189,56212,20013,83614,771
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa9,79126,98038,9965,25916,328
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+20.25%+175.56%+44.54%-86.51%+210.48%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa23.51%33.19%38.87%8.99%25.66%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-1,098-1,089-673-109-2,546
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2.66%+0.82%+38.2%+83.8%-2,235.78%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-1,449-1,291-1,238-2,209-3,091
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa3512025652,100545
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa1,9372,3751,9021,9441,169
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa10,63028,26640,2257,09414,951
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-237--222-
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-3,019-3,848-1,998-3,849-3,897
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,03624,31034,7291,0588,023
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-37.84%+245.51%+42.86%-96.95%+658.32%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa16.89%29.91%34.61%1.81%12.61%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa3701,8523,328-1,115-28
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa9,19522,02431,4072,1588,062
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-36-45-35-39-31
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa9,15921,97931,3722,1198,031
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-42.85%+139.97%+42.74%-93.25%+279%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa21.99%27.04%31.27%3.62%12.62%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa6,63022,41331,3662,1348,020
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.1945.590.381.42
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-37.92%+235.28%+39.77%-93.24%+274.43%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.183.935.470.371.41
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-37.46%+233.05%+39.19%-93.24%+281.08%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa5,5555,6015,6085,6435,664
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa5,6325,7085,7335,7095,700
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa1.521.561.61.641.68
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+5.56%+2.63%+2.56%+2.5%+2.44%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa